Mark Alles
President på
Acetylon Pharmaceuticals, Inc.
Profil
Mark J.
Alles is currently Chairman at Wugen, Inc. since 2023, Chairman at AI Proteins, Inc. since 2023, Chairman at TORL Biotherapeutics LLC with a title start in 2026, Trustee at Misericordia University, and President at Acetylon Pharmaceuticals, Inc. Former roles include Chairman & Chief Executive Officer at Celgene Corp.
from 2018 to 2019, Chairman at Turning Point Therapeutics, Inc. from 2021 to 2022, Independent Director at Syros Pharmaceuticals, Inc. from 2019 to 2023, Independent Non-Executive Director at Antengene Corp.
Ltd. from 2020 to 2023, Independent Director at BioMarin Pharmaceutical, Inc. from 2022 to 2024, Vice President-Oncology Business Unit at Aventis Pharmaceuticals, Inc. from 1993 to 2004, and Director or Principal positions at Biotechnology Innovation Organization, Pharmaceutical Research & Manufacturers of America, European Federation of Pharmaceutical Industries & Assns, Gilda's Club New York City, Inc., Juno Therapeutics, Inc., Centocor, Inc., Bayer Corp., and Trustee at HealthCare Institute of New Jersey.
Education includes an undergraduate degree from Lock Haven University of Pennsylvania conferred in 1981.
Aktiva positioner av Mark Alles
| Företag | Position | Start |
|---|---|---|
Acetylon Pharmaceuticals, Inc.
 Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical technology | President | - |
Wugen, Inc.
 Wugen, Inc. Packaged SoftwareTechnology Services Develops CAR-T therapy platform for cancer therapies | Ordförande | 2023-05-10 |
TORL Biotherapeutics LLC
 TORL Biotherapeutics LLC BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops antibody-based medicines for cancer patients | Ordförande | 2024-01-09 |
Misericordia University
 Misericordia University Other Consumer ServicesConsumer Services Functions as a College/University | Direktör/Styrelseledamot | - |
AI Proteins, Inc.
 AI Proteins, Inc. Packaged SoftwareTechnology Services Develops AI powered protein therapeutics discovery platform | Ordförande | 2023-08-08 |
Tidigare kända positioner av Mark Alles
| Företag | Position | Slut |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Direktör/Styrelseledamot | 2024-05-21 |
| SYROS PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2023-09-30 |
| ANTENGENE CORPORATION LIMITED | Direktör/Styrelseledamot | 2023-04-14 |
| TURG POIN | Ordförande | 2022-08-17 |
| ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Mark Alless utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
72
Första gradens relationer
20
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 20 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Health Technology |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products | Health Technology |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage structure-based drug design company for discovery and development of precision medicines for cancer and other diseases | Health Technology |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Misericordia University
Misericordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lock Haven University of Pennsylvania
 Lock Haven University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Commercial Services |
HealthCare Institute of New Jersey
 HealthCare Institute of New Jersey The private company is based in Bridgewater, NJ. The HealthCare Institute of New Jersey (HINJ) is a trade association representing research-based biopharmaceutical and medical technology companies. It advocates for policies that expand patient access to medicines, medical devices, vaccines, and diagnostics, and promotes value-based healthcare and fair drug pricing. HINJ supports legislation on antimicrobial resistance and diagnostic regulation modernization, monitors policy to foster a competitive life sciences ecosystem, and emphasizes corporate social responsibility, including philanthropy, community engagement, environmental sustainability, and employee volunteerism. The organization advances diversity, equity, and inclusion initiatives, collaborates with government, academia, and industry partners, and administers patient assistance programs such as the Rx4NJ partnership and promotes awareness of NJSAVE. Christine Buteas has been the CEO of the company since 2024. | |
Gilda's Club New York City, Inc.
 Gilda's Club New York City, Inc. Miscellaneous Commercial ServicesCommercial Services Provides support services to cancer patients | Commercial Services |
Acetylon Pharmaceuticals, Inc.
Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical technology | Health Technology |
Syros Pharmaceuticals, Inc.
 Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Wugen, Inc.
Wugen, Inc. Packaged SoftwareTechnology Services Develops CAR-T therapy platform for cancer therapies | Technology Services |
Antengene Corp. Ltd.
 Antengene Corp. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes hematologic malignancies therapies | Health Technology |
AI Proteins, Inc.
AI Proteins, Inc. Packaged SoftwareTechnology Services Develops AI powered protein therapeutics discovery platform | Technology Services |
TORL Biotherapeutics LLC
TORL Biotherapeutics LLC BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops antibody-based medicines for cancer patients | Health Technology |
